67Cu-SAR-bisPSMA
Phase 3- Indications
- Prostate cancer
Company intelligence / Profile preview
Sydney Angels is one of Australia’s oldest and most active angel investor groups, established in 2008. It has over 100 members who collectively invest in early-stage Australian startups across diverse sectors—including biotechnology and medical devices—via direct syndicates and the $10M Sydney Angels Sidecar Fund. The group has invested over AUD $41 million into more than 90 startups, which have subsequently raised over $780 million in follow-on funding. Notable exits include Atomo Diagnostics (ASX IPO), Clarity Pharmaceuticals (ASX IPO), Instaclustr (acquired by NetApp), and Aurtra (acquired by Schneider Electric). Members benefit from structured deal screening cycles, collaborative due diligence, and access to high-growth opportunities selected from hundreds of annual applicants
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sydney Angels.